KGC Korea Officially Launches High-performance M4s 4POT Brake Kit
Installed on the front wheel of passenger vehicle or SUV to improve braking performance A…
5 years ago
Realtime Robotics Opens Japan Office to Meet Growing Demand for Robotic Motion Control Solutions
New Office Incorporates Lab and Demonstration Space, Enabling Customers, Partners and Prospects to Engage With…
5 years ago
Cloudflare Takes On Email Security
Announces free email routing and anti-phishing configuration, and customer sign up for early access to…
5 years ago
Guardicore Collaborates with Amdocs to Elevate Globe Telecom’s Cloud Security
Guardicore’s Centra Security Platform will provide software-based segmentation to significantly improve Globe’s cloud security environment…
5 years ago
BIO-key Expands Product Line and Market Reach with Launch of FIDO2 Compliant Security Keys in a Variety of Form Factors
WALL, N.J., Sept. 27, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative…
5 years ago
Fabrinet Receives Cisco 2021 EMS Partner of the Year Award
BANGKOK--(BUSINESS WIRE)--#Fabrinet--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical…
5 years ago
Fabrinet Receives Cisco 2021 EMS Partner of the Year Award
BANGKOK--(BUSINESS WIRE)--#Fabrinet--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical…
5 years ago
Bio-Thera Solutions and Intract Pharma Enter Global Collaboration and License Agreement for Soteria® and Phloral® Drug Delivery Technologies to Enable Development of Oral Antibody Medicines
GUANGZHOU, China--(BUSINESS WIRE)--#IBD--Bio-Thera Solutions, Ltd. (688177.SH, “Bio-Thera”) and Intract Pharma (“Intract”) announced a global collaboration…
5 years ago
Bio-Thera Solutions and Intract Pharma Enter Global Collaboration and License Agreement for Soteria® and Phloral® Drug Delivery Technologies to Enable Development of Oral Antibody Medicines
GUANGZHOU, China--(BUSINESS WIRE)--#IBD--Bio-Thera Solutions, Ltd. (688177.SH, “Bio-Thera”) and Intract Pharma (“Intract”) announced a global collaboration…
5 years ago
AnHeart and Innovent Announce Interim Data from Phase ? Trial (TRUST) of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting
In the crizotinib treatment-naïve patient group (n=21), the confirmed objective response rate (ORR) was 90.5%…
5 years ago